Healthcare Realty Trust Incorporated (NYSE:HR) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. cut its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR) by 31.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 10,131 shares of the real estate investment trust’s stock after selling 4,562 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Healthcare Realty Trust were worth $171,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in HR. Blue Trust Inc. lifted its holdings in Healthcare Realty Trust by 130.3% in the 4th quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of Healthcare Realty Trust in the third quarter valued at about $65,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Healthcare Realty Trust in the third quarter worth about $78,000. Harbor Capital Advisors Inc. acquired a new position in Healthcare Realty Trust during the third quarter worth about $89,000. Finally, Trust Point Inc. purchased a new stake in Healthcare Realty Trust during the 3rd quarter valued at about $182,000.

Healthcare Realty Trust Stock Performance

HR stock opened at $16.54 on Friday. Healthcare Realty Trust Incorporated has a one year low of $12.77 and a one year high of $18.90. The firm has a market cap of $5.86 billion, a PE ratio of -10.47 and a beta of 0.94. The firm’s 50 day moving average price is $16.77 and its 200-day moving average price is $17.45.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on HR shares. Jefferies Financial Group lowered shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and decreased their target price for the stock from $19.00 to $17.00 in a research note on Thursday, January 2nd. Wedbush downgraded Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $18.00 to $16.00 in a research report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. lowered Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price objective on the stock. in a research note on Friday, December 20th. Two investment analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $17.00.

Insiders Place Their Bets

In other news, Director Thomas N. Bohjalian bought 7,750 shares of the business’s stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $17.39 per share, with a total value of $134,772.50. Following the completion of the transaction, the director now directly owns 50,002 shares in the company, valued at $869,534.78. This trade represents a 18.34 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Robert E. Hull sold 10,000 shares of the company’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $17.48, for a total value of $174,800.00. Following the transaction, the chief operating officer now owns 171,400 shares in the company, valued at $2,996,072. This trade represents a 5.51 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders acquired a total of 18,750 shares of company stock valued at $323,723 over the last quarter. 0.56% of the stock is owned by insiders.

Healthcare Realty Trust Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.